Skip to main content
NIH
Forecasted

PAR-26-027

Centers of Biomedical Research Excellence: Development Phase (COBRE-D)

Summary

AI-generated

NIGMS Institutional Development Awards (IDeA): COBRE Development Phase

The Centers of Biomedical Research Excellence: Development Phase (COBRE-D) program builds biomedical research capacity in states historically underrepresented in NIH funding. It targets institutions seeking to establish or expand research programs in strategic scientific areas where they currently lack infrastructure or expertise. COBRE-D funds institutional development across multiple research fields—including molecular biology, genetics, computational biology, and related biomedical disciplines—by supporting early-career investigator recruitment and retention. The program emphasizes long-term institutional vision through mentoring programs, supplemented start-up packages for new faculty hires, research facility establishment, and enhanced research administration services. COBRE-D is designed as a pathway for less-resourced institutions to eventually transition to the more advanced COBRE Expansion/Sustainability Phases.

  • Who can apply: Institutions in IDeA-eligible states (historically low NIH funding); must demonstrate institutional commitment to building capacity in targeted research areas.
  • Funding & project length: Not stated.
  • Award mechanism: P20 (institutional development award).
  • Key dates: Not stated.
  • Best fit for: Research institutions in under-resourced states seeking to develop new biomedical research programs through faculty recruitment, mentoring infrastructure, and facility investment.

Insights (6)

IDeA state residency is a hard gate; verify institutional eligibility before investing effort

eligibility

COBRE-D is restricted to institutions in historically low-NIH-funding states. This is not a soft preference—if your institution is not in an IDeA state, you are ineligible regardless of research merit. Confirm your state's current IDeA status with your grants office, as the list is updated periodically.

Early-career recruitment and mentoring are core program priorities, not add-ons

strategic fit

COBRE-D explicitly targets institutions building capacity to attract and retain early-career investigators. If your institution's strategic plan centers on recruiting ESIs and establishing mentoring infrastructure, this mechanism aligns directly with your goals. Conversely, if your institution is primarily focused on sustaining existing senior investigator programs, this may not be the optimal fit.

COBRE-D is a pathway mechanism; plan for transition to COBRE E/S sustainability funding

career stage

COBRE-D is explicitly framed as a 'development phase' and 'on-ramp' to COBRE E/S. This means the program expects institutions to build capacity during the award period and transition to expansion/sustainability funding. If your institution lacks a multi-year strategic vision for research growth and eventual independence from development support, this mechanism may not align with your timeline.

Broad scientific scope allows institutional flexibility; define your strategic niche early

strategic fit

COBRE-D supports 'broad scientific areas of strategic importance' to the institution, not narrow NIH priorities. This flexibility is an advantage—you can align the program with your institution's existing strengths or emerging opportunities. However, you must articulate a clear, defensible rationale for why your chosen research area is strategically important and why your institution currently lacks capacity. Vague or overly broad scientific scope will weaken competitiveness.

Multi-institutional consortia strengthen COBRE-D applications; leverage regional partnerships

collaboration

While not explicitly required, COBRE-D applications benefit from demonstrating how the center will build regional research networks and partnerships. If your institution can position itself as a hub for biomedical research capacity building in your IDeA state or region, this strengthens the institutional development narrative and increases the likelihood of sustained funding.

COBRE-D is moderately competitive; success depends on institutional commitment and infrastructure planning

competition

As a P20 mechanism with a defined pool of eligible institutions (IDeA states), competition is more focused than R01s but still substantial. Reviewers will assess not just research merit but institutional readiness: Does leadership commit resources? Are mentoring and administrative support systems in place? Is there a realistic plan to transition to COBRE E/S? Institutions with demonstrated institutional buy-in and infrastructure planning will be more competitive.

Key Facts

Deadline

Posted

Wed, September 17, 2025

P20
93.859
Grants.gov

Keywords

biomedical research capacity building
institutional development
early-career investigator recruitment
research infrastructure development
research mentoring programs
start-up package supplementation
research facilities establishment
research administration support
IDeA states
scientific research expansion

Research Areas

NIH Institute
General Medical SciencesNIGMS
OpenAlex
Life SciencesD1Health SciencesD4
Fields
Biochemistry, Genetics & Molecular BiologyF13Immunology & MicrobiologyF24MedicineF27NeuroscienceF28Pharmacology, Toxicology & PharmaceuticsF30
Subfields
BiochemistryS1303BiotechnologyS1305Molecular BiologyS1312Biochemistry (Medical)S2704EpidemiologyS2713Health InformaticsS2718Public Health & Occupational HealthS2739Pharmaceutical ScienceS3003
Topics
Health and Medical Research ImpactsT12168Machine Learning in BioinformaticsT12254Medical Education and AdmissionsT12602Medical and Health Sciences ResearchT13275Diverse Approaches in Healthcare and Education StudiesT13751Genetics, Bioinformatics, and Biomedical ResearchT13937Biotechnology and Related FieldsT14293
MeSH
Analytical/Diagnostic/Therapeutic TechniquesE
Disciplines & OccupationsH
Health OccupationsH02
Anthropology/Education/SociologyI
EducationI02
Health CareN
Health Care ServicesN02Health Care EconomicsN03Health Services AdministrationN04Health Care Quality & EvaluationN05
ANZSRC FoR
Biological Sciences31
Biochemistry & Cell Biology3101Bioinformatics & Computational Biology3102Microbiology3107
Biomedical & Clinical Sciences32
Clinical Sciences3202Medical Biotechnology3206
Commerce & Management35
Strategy & Management3507
Education39
Specialist Studies in Education3904
Engineering40
Biomedical Engineering4003

AI-generated content — verify with the issuing agency’s official FOA/NOFO. Not endorsed by HHS.

© 2026 Biostochastics, Seattle WA · Contact · Terms · About